直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

Stricter Assessment of Assignment Documents by the EPO

25 October 2017

Authored and Edited by Hazel Ford, Ph.D.; Leythem A. Wall

The European Patent Office (EPO) has recently introduced more stringent checking of documents filed in support of a transfer of rights.  This will apply whenever the EPO is asked to update its records of the ownership of a patent application or patent in view of an assignment of rights or other transfer. This is not expected to affect assignments that have already been recorded by the EPO or assignments that are recorded elsewhere, for example if an assignment is recorded with the International Bureau of WIPO before a PCT application is brought into the national phase at the EPO.

In November 2016, the EPO updated its Guidelines for Examination to require that assignment documents be signed by all parties to the agreement[1]. An assignment document that has been signed only by the assignor is not acceptable for recordal of a change of ownership at the EPO.

In addition, the EPO has now introduced additional checks relating to the individuals who have signed the assignment document[2]. If a person signs an assignment document on behalf of a company or other legal entity, the person’s name and their entitlement to sign on behalf of that party should be indicated on the document alongside their signature. The EPO will then examine whether the signatories indicated in the assignment document had the authority to enter into a legally binding contract on behalf of the relevant parties. The EPO will only accept signatories that it is satisfied were entitled to sign by law, by the company’s articles of association or equivalent, or by a special mandate, on the date when the assignment was signed. 

If the EPO is not satisfied on the face of the documents that the signatories had authority to sign, then it will request further evidence.  The assignment will not be recorded by the EPO until satisfactory evidence is provided.

It is understood that persons having certain positions within a company, such as the President, Chairman, Chief Executive, or a company Director, will be assumed by the EPO to have the authority to sign and the ability to authorise others to do so. However, a mere statement that someone is an “Authorised Signatory”, with no supporting evidence, or an indication of a position that does not automatically imply authority to enter into such an agreement (such as “General Counsel” or “Director of Operations”), is likely to result in a request for supporting evidence. If entitlement to sign results from a special authorisation, then a copy of the authorisation will need to be submitted.

The process of recording assignments with the EPO is likely to be quicker and simpler if supporting evidence of authority to sign is provided when the assignment document is filed at the EPO.  Because the EPO requires the signatures of both the assignor and assignee, it should be ensured that the relevant evidence of authority is obtained from both parties when an assignment is completed. 

[1] See our earlier blog post at https://www.finnegan.com/en/insights/blogs/european-ip-blog/stricter-rules-for-patent-assignments-in-europe.html

[2] EPO Guidelines for Examination, November 2017 edition, E-XIV, 3

Tags

assignment, European Patent Office (EPO)

Copyright © 2017 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Webinar

Implementation of Long-Arm Jurisdiction by the UPC Court and German National Courts: Strategic Considerations and Practical Implications

May 12, 2026

Webinar

Charitable

2026 National Inventors Hall of Fame Induction Ceremony

May 7, 2026

Washington, DC

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP